ABSTRACT
Imaging of the liver has progressed rapidly during the past decade with continued
advancement of current ultrasound, computed tomography, and magnetic resonance imaging
(MRI). Each modality not only has seen refinement enabling better anatomic characterization
of disease but also has received strength from the addition of new techniques to its
resources. New contrast agents have become available for all modalities and some agents,
particularly for MRI, have opened the way for better functional assessment. MRI continues
to see an elaboration of sequences (including spectroscopy and diffusion) that also
open imaging to the microscopic structure of disease and normal function. The further
development of workstations have improved both analysis and depiction of disease.
In the 21st century imaging will continue to shift from a simple source of anatomic
information to a more functional problem-solving tool.
KEYWORDS
Liver imaging - contrast agents - diffusion - spectroscopy - reformatting - computed
tomography - magnetic resonance imaging - ultrasound
REFERENCES
- 1
Gambarin-Gelwan M, Wolf D C, Shapiro R, Schwartz M E, Min A D.
Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma
in cirrhotic patients undergoing liver transplantation.
Am J Gastroenterol.
2000;
95
1535-1538
- 2
Chalasani N, Horlander Sr J C, Said A et al..
Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
Am J Gastroenterol.
1999;
94
2988-2993
- 3
Federle M P.
Use of radiologic techniques to screen for hepatocellular carcinoma.
J Clin Gastroenterol.
2002;
35
S92-S100
- 4
Colli A, Fraquelli M, Casazza G et al..
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein
in diagnosing hepatocellular carcinoma: a systematic review.
Am J Gastroenterol.
2006;
101
513-523
- 5
Dodd III G D, Zajko A B, Orons P D, Martin M S, Eichner L S, Santaguida L A.
Detection of transjugular intrahepatic portosystemic shunt dysfunction: value of duplex
Doppler sonography.
AJR Am J Roentgenol.
1995;
164
1119-1124
- 6
Haskal Z J, Carroll J W, Jacobs J E et al..
Sonography of transjugular intrahepatic portosystemic shunts: detection of elevated
portosystemic gradients and loss of shunt function.
J Vasc Interv Radiol.
1997;
8
549-556
- 7
Zizka J, Elias P, Krajina A et al..
Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt
malfunction: a 5-year experience in 216 patients.
AJR Am J Roentgenol.
2000;
175
141-148
- 8
Kok T, Slooff M J, Thijn C J et al..
Routine Doppler ultrasound for the detection of clinically unsuspected vascular complications
in the early postoperative phase after orthotopic liver transplantation.
Transpl Int.
1998;
11
272-276
- 9
Uzochukwu L N, Bluth E I, Smetherman D H et al..
Early postoperative hepatic sonography as a predictor of vascular and biliary complications
in adult orthotopic liver transplant patients.
AJR Am J Roentgenol.
2005;
185
1558-1570
- 10
Fuss M, Salter B J, Cavanaugh S X et al..
Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal
malignancies.
Int J Radiat Oncol Biol Phys.
2004;
59
1245-1256
- 11
Milsom J W, Jerby B L, Kessler H, Hale J C, Herts B R, O'Malley C M.
Prospective, blinded comparison of laparoscopic ultrasonography vs. contrast-enhanced
computerized tomography for liver assessment in patients undergoing colorectal carcinoma
surgery.
Dis Colon Rectum.
2000;
43
44-49
- 12
Foroutani A, Garland A M, Berber E et al..
Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors.
Arch Surg.
2000;
135
933-938
- 13
Cervone A, Sardi A, Conaway G L.
Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal
liver lesions.
Am Surg.
2000;
66
611-615
- 14
Leen E, Angerson W J, Yarmenitis S et al..
Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound
contrast agent in Doppler investigation of focal hepatic lesions.
Eur J Radiol.
2002;
41
200-206
- 15
Beissert M, Delorme S, Mutze S et al..
Comparison of B-mode and conventional colour/power Doppler ultrasound, contrast-enhanced
Doppler ultrasound and spiral CT in the diagnosis of focal lesions of the liver: results
of a multicentre study.
Ultraschall Med.
2002;
23
245-250
- 16
von Herbay A, Vogt C, Willers R, Haussinger D.
Real-time imaging with the sonographic contrast agent SonoVue: differentiation between
benign and malignant hepatic lesions.
J Ultrasound Med.
2004;
23
1557-1568
- 17
Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M.
Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced
computed tomography in metastatic disease of the liver: diagnostic performance and
confidence.
Eur Radiol.
2006;
16
1599-1609
- 18
Leen E, Ceccotti P, Kalogeropoulou C, Angerson W J, Moug S J, Horgan P G.
Prospective multicenter trial evaluating a novel method of characterizing focal liver
lesions using contrast-enhanced sonography.
AJR Am J Roentgenol.
2006;
186
1551-1559
- 19
Hollett M D, Jeffrey Jr R B, Nino-Murcia M, Jorgensen M J, Harris D P.
Dual-phase helical CT of the liver: value of arterial phase scans in the detection
of small (< or = 1.5 cm) malignant hepatic neoplasms.
AJR Am J Roentgenol.
1995;
164
879-884
- 20
Oliver III J H, Baron R L, Federle M P, Rockette Jr H E.
Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging
or both used in conjunction with conventional portal venous phase contrast-enhanced
CT imaging.
AJR Am J Roentgenol.
1996;
167
71-77
- 21
Yeh B M, Breiman R S, Taouli B, Qayyum A, Roberts J P, Coakley F V.
Biliary tract depiction in living potential liver donors: comparison of conventional
MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography-initial
experience.
Radiology.
2004;
230
645-651
- 22
Wang Z J, Yeh B M, Roberts J P, Breiman R S, Qayyum A, Coakley F V.
Living donor candidates for right hepatic lobe transplantation: evaluation at CT cholangiography-initial
experience.
Radiology.
2005;
235
899-904
- 23
Matsui O, Takashima T, Kadoya M et al..
Liver metastases from colorectal cancers: detection with CT during arterial portography.
Radiology.
1987;
165
65-69
- 24
Heiken J P, Weyman P J, Lee J K et al..
Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT
during arterial portography, and MR imaging.
Radiology.
1989;
171
47-51
- 25
Kondo H, Kanematsu M, Hoshi H et al..
Preoperative detection of malignant hepatic tumors: comparison of combined methods
of MR imaging with combined methods of CT.
AJR Am J Roentgenol.
2000;
174
947-954
- 26
Semelka R C, Martin D R, Balci C, Lance T.
Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR
imaging including dynamic gadolinium enhancement.
J Magn Reson Imaging.
2001;
13
397-401
- 27
Rode A, Bancel B, Douek P et al..
Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI
and correlation with pathologic examination of explanted liver.
J Comput Assist Tomogr.
2001;
25
327-336
- 28
Libbrecht L, Bielen D, Verslype C et al..
Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of
pretransplantation imaging examinations.
Liver Transpl.
2002;
8
749-761
- 29
Burrel M, Llovet J M, Ayuso C et al..
MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation:
an explant correlation.
Hepatology.
2003;
38
1034-1042
- 30
Soyer P, de Givry S C, Gueye C, Lenormand S, Somveille E, Scherrer A.
Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted
fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo,
and gadolinium chelate-enhanced 3D gradient-recalled imaging.
AJR Am J Roentgenol.
1996;
166
1115-1121
- 31
Fujita T, Ito K, Honjo K, Okazaki H, Matsumoto T, Matsunaga N.
Detection of hepatocellular carcinoma: comparison of T2-weighted breath-hold fast
spin-echo sequences and high-resolution dynamic MR imaging with a phased-array body
coil.
J Magn Reson Imaging.
1999;
9
274-279
- 32
Coulam C H, Chan F P, Li K C.
Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled
echo sequence be sufficient for liver MR imaging?.
AJR Am J Roentgenol.
2002;
178
335-341
- 33
Hecht E M, Holland A E, Israel G M et al..
Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted
MR imaging as a stand-alone sequence for diagnosis.
Radiology.
2006;
239
438-447
- 34
Sodickson A, Mortele K J, Barish M A, Zou K H, Thibodeau S, Tempany C M.
Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional
single-shot fast spin-echo techniques.
Radiology.
2006;
238
549-559
- 35
Kapoor V, Peterson M S, Baron R L, Patel S, Eghtesad B, Fung J J.
Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir
trisodium-enhanced MR cholangiography and intraoperative cholangiography.
AJR Am J Roentgenol.
2002;
179
1281-1286
- 36
Bridges M D, May G R, Harnois D M.
Diagnosing biliary complications of orthotopic liver transplantation with mangafodipir
trisodium-enhanced MR cholangiography: comparison with conventional MR cholangiography.
AJR Am J Roentgenol.
2004;
182
1497-1504
- 37
Goyen M, Schroeder T, Ruehm S G, Debatin J F.
MR-based assessment of potential living related liver donors.
Eur Radiol.
2004;
14(suppl 7)
O36-O40
- 38
Akin E B, Vitellas K M, Rajab A et al..
Magnetic resonance cholangiography with mangafodipir trisodium (Teslascan) to evaluate
bile duct leaks after T-tube removal in liver transplantation.
J Comput Assist Tomogr.
2004;
28
613-616
- 39
Ayuso J R, Ayuso C, Bombuy E et al..
Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric
mangafodipir trisodium enhanced magnetic resonance cholangiography.
Liver Transpl.
2004;
10
1391-1397
- 40
Lee V S, Krinsky G A, Nazzaro C A et al..
Defining intrahepatic biliary anatomy in living liver transplant donor candidates
at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted
MR cholangiography.
Radiology.
2004;
233
659-666
- 41
Lim J S, Kim M J, Kim J H et al..
Preoperative MRI of potential living-donor-related liver transplantation using a single
dose of gadobenate dimeglumine.
AJR Am J Roentgenol.
2005;
185
424-431
- 42
Moseley M E, Cohen Y, Mintorovitch J et al..
Early detection of regional cerebral ischemia in cats: comparison of diffusion- and
T2-weighted MRI and spectroscopy.
Magn Reson Med.
1990;
14
330-346
- 43
Taouli B, Vilgrain V, Dumont E, Daire J L, Fan B, Menu Y.
Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions
with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients.
Radiology.
2003;
226
71-78
- 44
Quan X Y, Sun X J, Yu Z J, Tang M.
Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal
hepatic lesions: a quantitative study in 56 cases.
Hepatobiliary Pancreat Dis Int.
2005;
4
406-409
- 45
Sun X J, Quan X Y, Huang F H, Xu Y K.
Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal
hepatic lesions.
World J Gastroenterol.
2005;
11
6535-6537
- 46
Nasu K, Kuroki Y, Nawano S et al..
Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR
imaging.
Radiology.
2006;
239
122-130
- 47
Boulanger Y, Amara M, Lepanto L et al..
Diffusion-weighted MR imaging of the liver of hepatitis C patients.
NMR Biomed.
2003;
16
132-136
- 48
Koinuma M, Ohashi I, Hanafusa K, Shibuya H.
Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance
imaging for evaluation of hepatic fibrosis.
J Magn Reson Imaging.
2005;
22
80-85
- 49
Ross B D, Moffat B A, Lawrence T S et al..
Evaluation of cancer therapy using diffusion magnetic resonance imaging.
Mol Cancer Ther.
2003;
2
581-587
- 50
Chen C Y, Li C W, Kuo Y T et al..
Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization:
choline levels and MR diffusion constants-initial experience.
Radiology.
2006;
239
448-456
- 51
Jackson A, Haroon H, Zhu X P, Li K L, Thacker N A, Jayson G.
Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic
resonance imaging and a first-pass leakage profile model.
NMR Biomed.
2002;
15
164-173
- 52
Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers B E.
Hepatic flow parameters measured with MR imaging and Doppler US: correlations with
degree of cirrhosis and portal hypertension.
Radiology.
2003;
229
409-414
- 53
Yoshioka H, Takahashi N, Yamaguchi M, Lou D, Saida Y, Itai Y.
Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular
hepatocellular carcinomas.
J Magn Reson Imaging.
2002;
16
259-266
- 54
Tanoli T, Yue P, Yablonskiy D, Schonfeld G.
Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal
adipose tissue, and insulin sensitivity.
J Lipid Res.
2004;
45
941-947
- 55
Machann J, Thamer C, Schnoedt B et al..
Hepatic lipid accumulation in healthy subjects: a comparative study using spectral
fat-selective MRI and volume-localized 1H-MR spectroscopy.
Magn Reson Med.
2006;
55
913-917
- 56
Cho S G, Kim M Y, Kim H J et al..
Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation
with histopathologic findings.
Radiology.
2001;
221
740-746
- 57
Lim A K, Patel N, Hamilton G, Hajnal J V, Goldin R D, Taylor-Robinson S D.
The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis
C.
Hepatology.
2003;
37
788-794
- 58
Dezortova M, Taimr P, Skoch A, Spicak J, Hajek M.
Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.
World J Gastroenterol.
2005;
11
6926-6931
- 59
Zakian K L, Koutcher J A, Malhotra S et al..
Liver regeneration in humans is characterized by significant changes in cellular phosphorus
metabolism: assessment using proton-decoupled 31P-magnetic resonance spectroscopic
imaging.
Magn Reson Med.
2005;
54
264-271
- 60
Chu W C, Lam W W, Lee K H, Yeung D K, Sihoe J, Yeung C K.
Phosphorus-31 MR spectroscopy in pediatric liver transplant recipients: a noninvasive
assessment of graft status with correlation with liver function tests and liver biopsy.
AJR Am J Roentgenol.
2005;
184
1624-1629
- 61
Planchamp C, Montet X, Frossard J L et al..
Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers.
Invest Radiol.
2005;
40
187-194
- 62
Matsuo M, Kanematsu M, Itoh K et al..
Detection of malignant hepatic tumors: comparison of gadolinium- and ferumoxide-enhanced
MR imaging.
AJR Am J Roentgenol.
2001;
177
637-643
- 63
Kwak H S, Lee J M, Kim Y K, Lee Y H, Kim C S.
Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced
dynamic three-dimensional volume interpolated breath-hold MR imaging.
Eur Radiol.
2005;
15
140-147
- 64
Simon G, Link T M, Wortler K et al..
Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced
MR imaging.
Eur Radiol.
2005;
15
895-903
- 65
Kato H, Kanematsu M, Kondo H et al..
Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic
tumor grade and tumor vascularity.
J Magn Reson Imaging.
2004;
19
76-81
- 66
Kim Y K, Lee J M, Kim C S, Chung G H, Kim C Y, Kim I H.
Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic
phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced
MR imaging.
Eur Radiol.
2005;
15
220-228
- 67
Bartolozzi C, Donati F, Cioni D et al..
Detection of colorectal liver metastases: a prospective multicenter trial comparing
unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Eur Radiol.
2004;
14
14-20
- 68
Youk J H, Lee J M, Kim C S.
MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium
and gadopentetate dimeglumine contrast agents.
AJR Am J Roentgenol.
2004;
183
1049-1054
- 69
Scharitzer M, Schima W, Schober E et al..
Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic
resonance imaging.
J Comput Assist Tomogr.
2005;
29
181-190
- 70
Sahani D V, Kalva S P, Fischman A J et al..
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison
of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
AJR Am J Roentgenol.
2005;
185
239-246
- 71
Regge D, Campanella D, Anselmetti G C et al..
Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting
liver metastases from colorectal carcinoma.
Clin Radiol.
2006;
61
338-347
- 72
Gondolesi G E, Yoshizumi T, Bodian C et al..
Accurate method for clinical assessment of right lobe liver weight in adult living-related
liver transplant.
Transplant Proc.
2004;
36
1429-1433
- 73
Harada N, Shimada M, Yoshizumi T, Suehiro T, Soejima Y, Maehara Y.
A simple and accurate formula to estimate left hepatic graft volume in living-donor
adult liver transplantation.
Transplantation.
2004;
77
1571-1575
- 74
Salvalaggio P R, Baker T B, Koffron A J et al..
Liver graft volume estimation in 100 living donors: measure twice, cut once.
Transplantation.
2005;
80
1181-1185
- 75
Dodd III G D, Baron R L, Oliver III J H, Federle M P.
Spectrum of imaging findings of the liver in end-stage cirrhosis: part II, focal abnormalities.
AJR Am J Roentgenol.
1999;
173
1185-1192
- 76
Krinsky G A, Israel G.
Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging:
frequency in cirrhotic patients undergoing transplantation.
AJR Am J Roentgenol.
2003;
180
1023-1027
- 77
Yu J S, Kim Y H, Rofsky N M.
Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high
signal intensity lesions on nonenhanced T1-weighted images.
J Comput Assist Tomogr.
2005;
29
51-58
- 78
Sugiyama M, Sakahara H, Torizuka T et al..
18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.
J Gastroenterol.
2004;
39
961-968
Emil CohenM.D.
Department of Radiology, Box 1234, Mount Sinai Medical Center, One Gustave L. Levy
Place
New York, NY 10029-6574
Email: emil.cohen@mountsinai.org
